Study finds increased survival with nivolumab plus ipilimumab vs. chemo for metastatic colorectal cancer
For sufferers with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal most cancers who had not beforehand acquired systemic therapy, progression-free ...